首页> 外文学位 >A Novel Comprehensive Verification Method for Multifocal RapidArc Radiosurgery Treatments.
【24h】

A Novel Comprehensive Verification Method for Multifocal RapidArc Radiosurgery Treatments.

机译:一种用于多焦点RapidArc放射外科治疗的新颖的综合验证方法。

获取原文
获取原文并翻译 | 示例

摘要

Purpose: Radiosurgery has become a widely used procedure in the treatment of both solid tumors and secondary metastases in the brain. In cases with multiple brain lesions, isocenters are typically set up for each target, a process which can take hours and become very uncomfortable for the patient. Recently, multifocal treatments with a single isocenter have emerged as a solution. With the high doses delivered to small regions during radiosurgery, the importance of treatment verification is paramount, especially when delivering high doses to regions off isocenter.;Methods: A 5-arc RapidArc radiosurgery plan with a single isocenter and 5 targets was used to treat a dosimeter placed within a RPC-type head and neck phantom. The treatment was delivered five times at varying prescription doses, depending on the sensitivity of the PRESAGE dosimeter used. The delivered dose distribution was measured using an in-house optical-CT system and compared to the Eclipse-planned dose distribution using dose volume histograms and Gamma analysis.;Results: Reasonable dose agreement was measured between the majority of the dosimeters and the Eclipse plan (80-85% pass rate at 5%/3 mm Gamma critera). The failing voxels were located on the periphery of the dosimeter at regions of extremely high or low dose, suggesting a dose dependent stability of the PRESAGE formulation. The formulation with the best temporal stability had a much higher Gamma pass rate of 98% at 3%/2mm criteria.;Conclusions: The potential of accurate delivery of the complex radiosurgery plan was demonstrated with one of the three formulations of PRESAGE. While agreement was worse in the other formulations, the problem seemed to be an easily-fixable stability issue, resulting in improper scaling of doses. Replication of the most stable formulation would provide an excellent tool for verification of radiosurgery treatment delivery and other complex procedures.
机译:目的:放射外科手术已成为治疗实体瘤和脑继发转移的一种广泛使用的方法。在有多个脑部病变的情况下,通常会为每个目标建立等中心点,此过程可能需要数小时,并且会使患者感到非常不舒服。最近,作为解决方案出现了具有单个等中心的多焦点治疗。由于在放射外科手术期间将高剂量放射到较小的区域,治疗验证的重要性至关重要,尤其是在将高剂量放射到等中心点以外的区域时。方法:采用具有单个等中心点和5个靶标的5弧RapidArc放射外科手术计划放置在RPC型头颈幻影中的剂量计。根据所使用的PRESAGE剂量计的灵敏度,以不同的处方剂量进行五次治疗。使用内部光学CT系统测量交付的剂量分布,并使用剂量体积直方图和Gamma分析与Eclipse计划的剂量分布进行比较;结果:在大多数剂量计和Eclipse计划之间测量了合理的剂量一致性(在5%/ 3毫米伽玛灰黄铁矿上,合格率为80-85%)。失效的体素位于剂量计的外围,处于极高或极低剂量的区域,这表明PRESAGE制剂的剂量依赖性稳定性。具有最佳时间稳定性的制剂在3%/ 2mm的标准下具有更高的98%伽玛通过率。结论:PRESAGE的三种制剂之一证明了复杂放射外科手术计划的准确交付潜力。尽管在其他配方中一致性较差,但问题似乎是易于解决的稳定性问题,导致剂量比例不当。复制最稳定的制剂将为验证放射外科治疗的实施和其他复杂程序提供一个极好的工具。

著录项

  • 作者

    Niebanck, Michael Henry.;

  • 作者单位

    Duke University.;

  • 授予单位 Duke University.;
  • 学科 Health Sciences Radiology.;Health Sciences Oncology.
  • 学位 M.S.
  • 年度 2012
  • 页码 55 p.
  • 总页数 55
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号